Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus.

Author: Striepe, Kristina MD; Jumar, Agnes MD; Ott, Christian MD; Karg, Marina V. MD; Schneider, Markus P. MD; Kannenkeril, Dennis MD; Schmieder, Roland E. MD

Page: 1167-1169

http://ift.tt/2x9La2A